Advertisement
Screener

RETINALGENIX TECHNOLOGIES INC. (RTGN) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.8 / 5 stars · 68/120 Roast Me

RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-04-15

  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
  • RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-12-310.00%
10-K · filed 2026-04-15
2025-09-300.00%
10-Q · filed 2025-11-14
2025-06-300.00%
10-Q/A · filed 2025-08-20
2025-03-310.00%
10-Q · filed 2025-05-15
2024-12-310.00%
10-Q · filed 2025-05-15
2024-09-300.00%
10-Q · filed 2024-11-18
2024-06-300.00%
10-Q · filed 2024-08-19
2024-03-310.00%
10-Q · filed 2024-05-20
2023-12-310.00%
10-K · filed 2025-03-31
2023-09-300.00%
10-Q · filed 2024-11-18
2023-06-300.00%
10-Q · filed 2024-08-19
2022-12-310.00%
10-K · filed 2024-04-01
2022-09-300.00%
10-Q · filed 2022-11-17
2022-06-300.00%
10-Q · filed 2022-08-19
2022-03-310.00%
10-Q/A · filed 2022-05-16
2021-12-310.00%
10-K/A · filed 2023-06-15
2020-12-310.00%
10-Q · filed 2021-11-22